de los Pinos Elisabet 4
4 · Aura Biosciences, Inc. · Filed Oct 18, 2024
Insider Transaction Report
Form 4
de los Pinos Elisabet
DirectorSee Remarks
Transactions
- Sale
Common Stock
2024-10-18$12.04/sh−24,992$300,839→ 329,847 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-18−24,992→ 336,171 totalExercise: $2.74Exp: 2028-02-21→ Common Stock (24,992 underlying) - Exercise/Conversion
Common Stock
2024-10-18$2.74/sh+24,992$68,478→ 354,839 total
Holdings
- 131,412(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee.
- [F4]This option is fully vested.